Skip to Main Content

Amy Abernethy, the number two official at the Food and Drug Administration, plans to depart the agency in mid-to-late April.

The announcement was made in a memo from Janet Woodcock, the acting commissioner of the Food and Drug Administration, who called Abernethy “a talented and inspiring leader” and said she takes heart in Abernethy’s “enduring accomplishments.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!